Information Exchange and Data Transformation (INFORMED), a multidisciplinary initiative anchored in the FDA Oncology Center of Excellence, is a decentralized science and technology incubator designed to harness the power of big data and advanced analytics to improve disease outcomes.
Access options
Subscribe to Journal
Get full journal access for 1 year
$265.00
only $22.08 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
from$8.99
All prices are NET prices.
References
- 1.
Khozin, S. Kim, G. & Pazdur, R. From big data to smart data: FDA's INFORMED initiative. Nat. Rev. Drug Discov. 16, 306 (2017).
- 2.
Greene, J. A. & Loscalzo, J. Putting the patient back together — social medicine, network medicine, and the limits of reductionism. N. Engl. J. Med. 377, 2493–2499 (2017).
- 3.
Bertagnolli, M. M. et al. Advantages of a truly open-access data-sharing model. N. Engl. J. Med. 376, 1178–1181 (2017).
- 4.
Khozin, S. et al. Evaluating the potential for digital submission of expedited premarket safety reports to the FDA. Nat. Rev. Drug Discov. 15, 670–671 (2016).
Author information
Affiliations
US Food and Drug Administration, Department of Health and Human Services, Silver Spring, MD, USA.
- Sean Khozin
- , Richard Pazdur
- & Anand Shah
Centers for Medicare and Medicaid Services, Baltimore, MD, USA.
- Anand Shah
Authors
Search for Sean Khozin in:
Search for Richard Pazdur in:
Search for Anand Shah in:
Competing interests
The authors declare no competing financial interests.
Corresponding author
Correspondence to Sean Khozin.
Supplementary information
PDF files
- 1.
Supplementary information
Traditional versus systems view of drug development
Rights and permissions
To obtain permission to re-use content from this article visit RightsLink.
